Higher dose of Alzheimer's drug approved despite FDA warnings, report shows

Share this article:

Makers of the Alzheimer's drug Aricept released a higher dosage version of the medication despite concerns about side effects and reduced efficacy, a study reports.

Aricept, which was developed by the Japanese drugmaker Eisai and marketed by Pfizer in the United States, was set to lose its patent protection in November 2010, the New York Times reported. Eisai applied for a 23-milligram version of the drug — marketed as Aricept 23 — which would eliminate the need for patients or physicians to combine existing 5- and 10-milligram doses. Although the Aricept 23 caused more nausea and vomiting according to results of a clinical trial released this month, the drug was approved by the Food and Drug Administration. That drew the ire of some physicians.

“Rarely do we see such a dangerous difference between what pretty much everyone in the neurological division thought and what its leader thought,” Sidney M. Wolfe, M.D., director of Public Citizen's Health Research Group, told the New York Times.

Despite these concerns over potentially high dosages, British researchers also said this month that Alzheimer's drugs, including Aricept, are underused. 

Share this article:

More in News

House leader urges HHS to end settlements meant to cut Medicare backlog

The Department of Health and Human Services may not have had the authority to offer providers special settlements to help clear a huge backlog of Medicare appeals, a leading Congressman said in a recent letter to the agency. Rep. Kevin Brady (R-TX) is urging HHS ...

One-fifth of caregivers take 6 months or longer to choose a senior ...

A significant number of people take six months or longer to choose a senior care or housing option for a loved one, recently released survey results showed.

CMS releases updated Minimum Data Set manual

CMS releases updated Minimum Data Set manual

The Centers for Medicare & Medicaid Services released an updated version of the Minimum Data Set 3.0 Resident Assessment Instrument manual Friday.